News Image

Which stocks are gapping on Tuesday?

By Mill Chart

Last update: Apr 30, 2024

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.

Gap up stocks

TickerChangeComment
AGBA64.99%In today's session, AGBA GROUP HOLDING LTD's (NASDAQ:AGBA) stock experienced a notable rise of 64.99%, reaching $3.88 with a remarkable gap of 16.6%. Earlier today the company had a press release: Building a Digital Economy Titan: AGBA and Triller Combine in $4 Billion Merger.
AKLI63.73%AKILI INC (NASDAQ:AKLI) rose 63.73% to $0.38 with a gap of 45.66% during Tuesday's session. Earlier today the company had a press release: Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results.
CYCC48.53%Exciting news for CYCLACEL PHARMACEUTICALS INC's (NASDAQ:CYCC) stock! It advanced 48.53% to $2.02 in today's session, accompanied by a notable 20.0% gap. A press release (Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules) was released earlier today.
AGBAW45.0%AGBA ACQUISITION LTD -CW24's (NASDAQ:AGBAW) stock price is advancing with 45.0% to a price of $0.29 with a gap of 5.0%. Shareholders saw the stock price going 1.0K% higher in the past month.
WGS40.91%In today's session, GENEDX HOLDINGS CORP's (NASDAQ:WGS) stock experienced a notable rise of 40.91%, reaching $15.5 with a significant 23.42% gap. Yesterday the company had a press release: GeneDx Reports First Quarter 2024 Financial Results and Business Highlights.
UAVS21.43%AGEAGLE AERIAL SYSTEMS INC's (NYSEARCA:UAVS) shares soared 21.43% to $0.85 during Tuesday's session, accompanied by a significant gap of 3.55%. In the last 3 months the stock lost 48.29%.
MRIN20.69%MARIN SOFTWARE INC's (NASDAQ:MRIN) shares surged 20.69% to $3.15, accompanied by a significant 14.54% gap. Today NASDAQ:MRIN is releasing earnings. Yesterday the company had a press release: Marin Software Launches AI-powered Anomaly Detector to Unlock Growth in Performance Marketing Campaigns.
TREE20.44%In today's session, LENDINGTREE INC's (NASDAQ:TREE) stock experienced a notable rise of 20.44%, reaching $44.98 with a significant 11.64% gap. LENDINGTREE INC released earnings Yesterday. Shareholders saw the stock price going 132.0% higher is the past 6 months.
HLIT19.68%HARMONIC INC (NASDAQ:HLIT) rose 19.68% to $11.25 with a gap of 17.21% during Tuesday's session. In the last month the share price dropped with 28.02%.
CLW17.73%In today's session, CLEARWATER PAPER CORP's (NYSE:CLW) stock experienced a notable rise of 17.73%, reaching $47.91 with a significant 2.29% gap. Yesterday the company had a press release: Clearwater Paper Reports First Quarter 2024 Results.

Our gap up stocks screener will show you the full list.

Gap down stocks

TickerChangeComment
LICN-26.61%During Tuesday's session, LICHEN CHINA LTD- A's (NASDAQ:LICN) stock price decreased by 26.61% to $1.49 with a significant 28.92% gap. Shareholders saw the stock price going 86.24% higher in the past month.
MED-22.6%Today, MEDIFAST INC's (NYSE:MED) stock experienced a 22.6% fall to $27.48 with a 28.31% gap. A press release (Medifast Announces First Quarter 2024 Financial Results) was released yesterday.
CHGG-20.43%CHEGG INC's (NYSE:CHGG) shares declined by 20.43% to $5.71, showing a 21.61% gap in today's session. Yesterday the company had a press release: Chegg Announces Appointment of Nathan Schultz as Chief Executive Officer.
NRXP-20.42%NRX PHARMACEUTICALS INC's (NASDAQ:NRXP) shares experienced a 20.42% decline to $2.83 during Tuesday's session, accompanied by a 40.47% gap. In the last month the share price dropped with 32.38%.
HEES-18.14%H&E EQUIPMENT SERVICES INC's (NASDAQ:HEES) shares fell 18.14% to $48.48 during Tuesday's session with a gap of 18.91%. H&E EQUIPMENT SERVICES INC released earnings Yesterday. In the last 6 months the stock gained 36.01%.
CSLR-17.95%COMPLETE SOLARIA INC's (NASDAQ:CSLR) shares experienced a 17.95% decline to $0.6 during Tuesday's session, accompanied by a 24.88% gap. A press release (Complete Solaria to Report Fourth Quarter 2023 and First Quarter 2024 Financial and Operational Results on May 2, 2024) was released earlier today.
TCJH-16.39%TOP KINGWIN LTD-A's (NASDAQ:TCJH) shares fell 16.39% to $0.6 during Tuesday's session with a gap of 30.23%. In the last month the share price dropped with 53.1%.
LUCY-16.08%INNOVATIVE EYEWEAR INC's (NASDAQ:LUCY) stock price is declining with 16.08% to a price of $0.2 with a gap of 17.32%. In the last month the share price dropped with 21.09%.
RBT-13.6%Today, RUBICON TECHNOLOGIES INC's (NYSE:RBT) stock experienced a 13.6% fall to $0.42 with a 18.62% gap. In the last 3 months the stock lost 64.26%.
SINT-13.58%SINTX TECHNOLOGIES INC's (NASDAQ:SINT) shares suffered a 13.58% decline to $0.05 during Tuesday's session, accompanied by a 25.0% gap. The stock is trading 40.46% higher than a month ago.

For the full top loser list go to our gap down stocks screener.

Back

NRX PHARMACEUTICALS INC

NASDAQ:NRXP (5/9/2024, 10:35:30 AM)

2.81

-0.01 (-0.35%)

NRXP News

News Imagea day ago - InvezzNRx Pharmaceuticals eyes first commercial revenue in 2024, announces breakthroughs in bi-annual milestone update

Michigan, United States, April 29th, 2024, FinanceWire NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. NRXP is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and […]

News Imagea day ago - NRx Pharmaceuticals, Inc.NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024

/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced...

News Image2 days ago - NRx Pharmaceuticals, Inc.NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024

/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced...

News Image3 days ago - Get NewsFinal Clinical Trial Results Show Superior Safety and Efficacy for NRX-101; Plans to Seek Accelerated Approval for Bipolar Depression and Schizophrenia: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
News Image3 days ago - NRx Pharmaceuticals, Inc.NRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression

Both drugs demonstrated > 50% response for treating depression. NRX-101 demonstrated a mean 76% reduction in symptoms of akathisia compared to lurasidone that...

News Image8 days ago - ChartmillThese stocks are moving in today's pre-market session

Get insights into the top gainers and losers of Wednesday's pre-market session.

News Image9 days ago - ChartmillTuesday's after hours session: top gainers and losers

Which stocks are moving after the closing bell on Tuesday?

News Image9 days ago - ChartmillWhat's going on in today's session

Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

News Image9 days ago - ChartmillWhich stocks are moving on Tuesday?

Which stocks are experiencing notable movement on Tuesday?

News Image9 days ago - ChartmillWhich stocks are gapping on Tuesday?

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.

News Image9 days ago - NRx PharmaceuticalsNRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression

NRX-101 is first oral antidepressant to show 33% advantage in sustained remission in suicidality (not statistically significant at this sample size) and 75%...

News Image21 days ago - InvestorPlaceWhy Is Bio-Path (BPTH) Stock Up 89% Today?

Bio-Path stock is up with heavy trading of BPTH shares today alongside positive news from its ongoing clinical trial of BP1002.

NRXP Links
Follow us for more